These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33917046)

  • 1. Preparation and Preliminary Evaluation of Neurotensin Radiolabelled with
    Leonte RA; Chilug LE; Șerban R; Mustăciosu C; Raicu A; Manda G; Niculae D
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33917046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel DOTA-neurotensin analogues for 111In scintigraphy and 68Ga PET imaging of neurotensin receptor-positive tumors.
    Alshoukr F; Prignon A; Brans L; Jallane A; Mendes S; Talbot JN; Tourwé D; Barbet J; Gruaz-Guyon A
    Bioconjug Chem; 2011 Jul; 22(7):1374-85. PubMed ID: 21662976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Evaluation of NHS-Activated Gold Nanoparticles Functionalized with Bombesin or Neurotensin-Like Peptides for Targeting Colon and Prostate Tumours.
    Chilug LE; Niculae D; Leonte RA; Nan A; Turcu R; Mustaciosu C; Serban RM; Lavric V; Manda G
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32722221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of DOTA-chelated neurotensin analogs with spacer-enhanced biological performance for neurotensin-receptor-1-positive tumor targeting.
    Jia Y; Shi W; Zhou Z; Wagh NK; Fan W; Brusnahan SK; Garrison JC
    Nucl Med Biol; 2015 Nov; 42(11):816-23. PubMed ID: 26302836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of
    Fonseca Cabrera GO; Ma X; Lin W; Zhang T; Zhao W; Pan L; Li X; Barnhart TE; Aluicio-Sarduy E; Deng H; Wu X; Rakesh KP; Li Z; Engle JW; Wu Z
    J Nucl Med; 2024 Jun; ():. PubMed ID: 38871388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of
    Marenco M; Lodola L; Persico MG; Frangipane V; Facoetti A; Aprile C; Hodolič M
    Curr Pharm Biotechnol; 2018; 19(9):754-759. PubMed ID: 30160211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical PET Imaging of NTSR-1-Positive Tumors with
    Li D; Minnix M; Allen R; Bading J; Chea J; Wong P; Bowles N; Poku E; Shively JE
    Cancer Biother Radiopharm; 2021 Oct; 36(8):651-661. PubMed ID: 32822229
    [No Abstract]   [Full Text] [Related]  

  • 8. DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours.
    Zhang H; Schuhmacher J; Waser B; Wild D; Eisenhut M; Reubi JC; Maecke HR
    Eur J Nucl Med Mol Imaging; 2007 Aug; 34(8):1198-208. PubMed ID: 17262215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone targeting compounds for radiotherapy and imaging: *Me(III)-DOTA conjugates of bisphosphonic acid, pamidronic acid and zoledronic acid.
    Meckel M; Bergmann R; Miederer M; Roesch F
    EJNMMI Radiopharm Chem; 2017; 1(1):14. PubMed ID: 29564390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary results of biodistribution and dosimetric analysis of [
    Khawar A; Eppard E; Roesch F; Ahmadzadehfar H; Kürpig S; Meisenheimer M; Gaertner FC; Essler M; Bundschuh RA
    Ann Nucl Med; 2019 Jun; 33(6):404-413. PubMed ID: 30877560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theranostic cobalt-55/58m for neurotensin receptor-mediated radiotherapy in vivo: A pilot study with dosimetry.
    Lin W; Aluicio-Sarduy E; Houson HA; Barnhart TE; Tekin V; Jeffery JJ; Weichmann AM; Barrett KE; Lapi SE; Engle JW
    Nucl Med Biol; 2023; 118-119():108329. PubMed ID: 36805869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical Evaluation of
    Prignon A; Provost C; Alshoukr F; Wendum D; Couvelard A; Barbet J; Forgez P; Talbot JN; Gruaz-Guyon A
    Mol Pharm; 2019 Jun; 16(6):2776-2784. PubMed ID: 31013092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [
    Lau J; Kwon D; Rousseau E; Zhang Z; Zeisler J; Uribe CF; Kuo HT; Zhang C; Lin KS; Bénard F
    Mol Pharm; 2019 Nov; 16(11):4688-4695. PubMed ID: 31545614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer.
    de Visser M; Janssen PJ; Srinivasan A; Reubi JC; Waser B; Erion JL; Schmidt MA; Krenning EP; de Jong M
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1134-9. PubMed ID: 12768332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies.
    Weineisen M; Schottelius M; Simecek J; Baum RP; Yildiz A; Beykan S; Kulkarni HR; Lassmann M; Klette I; Eiber M; Schwaiger M; Wester HJ
    J Nucl Med; 2015 Aug; 56(8):1169-76. PubMed ID: 26089548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of new GnRH-I receptor radionuclide therapy with
    Zoghi M; Attar Nosrati S; Rogni F; Shirvani G; Johari Daha F
    J Labelled Comp Radiopharm; 2019 Jun; 62(7):310-320. PubMed ID: 31033025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of a novel, versatile bifunctional chelator on theranostic properties of a minigastrin analogue.
    Pfister J; Summer D; Rangger C; Petrik M; von Guggenberg E; Minazzi P; Giovenzana GB; Aloj L; Decristoforo C
    EJNMMI Res; 2015 Dec; 5(1):74. PubMed ID: 26669693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 68Ga/177Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology.
    Dalm SU; Bakker IL; de Blois E; Doeswijk GN; Konijnenberg MW; Orlandi F; Barbato D; Tedesco M; Maina T; Nock BA; de Jong M
    J Nucl Med; 2017 Feb; 58(2):293-299. PubMed ID: 27609789
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Liu F; Zhu H; Yu J; Han X; Xie Q; Liu T; Xia C; Li N; Yang Z
    Tumour Biol; 2017 Jun; 39(6):1010428317705519. PubMed ID: 28618966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma.
    Waked A; Crabbé M; Neirinckx V; Pérez SR; Wellens J; Rogister B; Benotmane MA; Vermeulen K
    EJNMMI Radiopharm Chem; 2024 Jul; 9(1):52. PubMed ID: 39008219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.